Sanofi may sell Alnwick R&D facility

French drugmaker Sanofi-Aventis may put its Alnwick Research Centre in Northumberland, UK up for sale, according various media reports.

Site director Roland Jurke told the Northumberland Gazette​ earlier this month that: “It is not anticipated that the Alnwick site will form part of Sanofi Aventis' future research and development site network​.”

Although Sanofi has yet to comment on the speculation, a recent article in French newspaper Le Figaro​ suggested that a potential Alnwick sale could be part of the reorganisation plans that the firm announced on June 30.

Around 170 people are currenctly employed by Sanofi at the facility in a variety of research and development (R&D) roles.

Related topics Markets & regulatory news

Related news

Follow us

Products

View more

Webinars